Dr. Rickard Brånemark and Magnus Niska to Appear on TV4 Nyhetsmorgon, Saturday, December 19[th], 09:20.
On Saturday morning, Dr. Rickard Brånemark, founder of Integrum AB, and Magnus Niska, the first patient in the world treated with Integrum’s revolutionary e-OPRATM Implant System, will be interviewed on the very popular TV show, Nyhetsmorgon, on channel 4 in Sweden.
During the interview, Dr. Brånemark will discuss this unique and revolutionary treatment, which has its foundation in Integrum’s OPRATM Implant System; technology which builds upon Rickard Brånemark’s research within osseointegrated prostheses, and offers amputee patients the unique opportunity to reclaim an active lifestyle, and leave the discomforts and shortcomings of traditional socket prostheses behind.
About the e-OPRATM Implant System
In January 2013, Dr. Brånemark led the world’s first surgery where neuromuscular electrodes were permanently implanted in Magnus, connecting the prosthesis to Magnus’ bone, nerves, and muscles. Today, robotic prostheses controlled via implanted neuromuscular interfaces are about to become a clinical reality thanks to Integrum’s osseointegrated technology. This technology is under development and currently in an ongoing clinical trial, and as soon as it is CE-marked it will be the natural upgrade for people using the OPRA™ Implant System.
Joining Dr. Brånemark on the program is Magnus, a 42 year old from Haparanda in Northern Sweden, who was the first person to receive a prosthesis with a direct connection to bone, nerves and muscles. Thanks to his new robotic arm, Magnus has been able to cope with all the situations he faces in his physically demanding job of driving big rigs between Sweden, Norway, and Finland.
For further information, please contact:
Maria Lopez, CEO
Cell. +46 (0) 708-46 10 69
Email: maria.lopez@integrum.se
Certified Adviser:
Erik Penser Bank AB
Tel. +46 (0) 8 463 8000
Email: certifiedadviser@penser.se
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North exchange) based outside of Gothenburg, Sweden with a U.S. subsidiary in San Francisco, CA. Since 1990 the OPRA™ Implant System has been helping individuals with amputations towards an improved quality of life. Thorough surgical experience gained over more than three decades from 500 surgeries in 14 countries has led to the development of Integrum’s system for bone-anchored prosthetics – a beneficial alternative to the traditionally used socket prosthesis. Integrum’s OPRA™ Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2015 for use in the U.S. under a Humanitarian Use Device (HUD) designation which was reviewed through the Humanitarian Device Exemption (HDE) pathway. The OPRA™ Implant System is the only FDA approved medical device for above-knee, bone-anchored prosthetics available in the U.S. More information on the company and its innovative solutions for amputees can be found at www.integrum.se.
